These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
817 related items for PubMed ID: 15770304
21. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Prieto M, Gómez MD, Berenguer M, Córdoba J, Rayón JM, Pastor M, García-Herola A, Nicolás D, Carrasco D, Orbis JF, Mir J, Berenguer J. Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423 [Abstract] [Full Text] [Related]
22. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria. Jeremiah ZA, Idris H, Ajayi BB, Ezimah AC, Malah MB, Baba MM. Hum Antibodies; 2011 Jan; 20(3-4):77-82. PubMed ID: 22129677 [Abstract] [Full Text] [Related]
23. Nucleic acid amplification technology for hepatitis B virus, and its role in blood donation screening in blood banks. Bamaga MS, Azahar EI, Al-Ghamdi AK, Alenzi FQ, Farahat FM. Saudi Med J; 2009 Nov; 30(11):1416-21. PubMed ID: 19882053 [Abstract] [Full Text] [Related]
26. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion. Asim M, Ali R, Khan LA, Husain SA, Singla R, Kar P. Indian J Med Res; 2010 Sep; 132():312-7. PubMed ID: 20847378 [Abstract] [Full Text] [Related]
30. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy. Sheng WH, Kao JH, Chen PJ, Huang LM, Chang SY, Sun HY, Hung CC, Chen MY, Chang SC. Clin Infect Dis; 2007 Nov 01; 45(9):1221-9. PubMed ID: 17918088 [Abstract] [Full Text] [Related]
31. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value? Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY. Transfusion; 2012 Feb 01; 52(2):440-6. PubMed ID: 21810101 [Abstract] [Full Text] [Related]
33. Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors. Seo DH, Whang DH, Song EY, Kim HS, Park Q. Transfusion; 2011 Aug 01; 51(8):1840-6. PubMed ID: 21332731 [Abstract] [Full Text] [Related]
34. Hepatitis B virus blood screening: unfinished agendas. Comanor L, Holland P. Vox Sang; 2006 Jul 01; 91(1):1-12. PubMed ID: 16756595 [Abstract] [Full Text] [Related]
37. The decline of hepatitis B viral infection in South-Western Saudi Arabia. Ayoola AE, Tobaigy MS, Gadour MO, Ahmad BS, Hamza MK, Ageel AM. Saudi Med J; 2003 Sep 01; 24(9):991-5. PubMed ID: 12973485 [Abstract] [Full Text] [Related]
38. Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT. Brojer E, Grabarczyk P, Liszewski G, Mikulska M, Allain JP, Letowska M, Polish Blood Transfusion Service Viral Study Group. Hepatology; 2006 Dec 01; 44(6):1666-74. PubMed ID: 17133474 [Abstract] [Full Text] [Related]
39. Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposure. Abdelmalek MF, Pasha TM, Zein NN, Persing DH, Wiesner RH, Douglas DD. Liver Transpl; 2003 Dec 01; 9(12):1253-7. PubMed ID: 14625824 [Abstract] [Full Text] [Related]
40. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B]. Altindiş M, Uslan I, Cetinkaya Z, Yüksel S, Ciftçi IH, Demirtürk N, Ozdemir M, Arslan F, Aktepe OC. Mikrobiyol Bul; 2007 Apr 01; 41(2):227-33. PubMed ID: 17682709 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]